Suero, Mark Kloe C.
HRN: 22-28-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2023
CEFUROXIME 1.5GM (VIAL)
04/02/2023
04/05/2023
IV
240mg
Q8
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes